News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
511,228 Results
Type
Article (40254)
Company Profile (116)
Press Release (470852)
Multimedia
Podcasts (104)
Webinars (15)
Section
Business (150674)
Career Advice (1773)
Deals (22456)
Drug Delivery (78)
Drug Development (60376)
Employer Resources (113)
FDA (11201)
Job Trends (10753)
News (247598)
Policy (21823)
Tag
Academia (2509)
Academic (2)
Accelerated approval (11)
Adcomms (21)
Allergies (85)
Alliances (42161)
ALS (124)
Alzheimer's disease (1540)
Antibody-drug conjugate (ADC) (161)
Approvals (11303)
Artificial intelligence (393)
Autoimmune disease (53)
Automation (23)
Bankruptcy (188)
Best Places to Work (8862)
BIOSECURE Act (18)
Biosimilars (96)
Biotechnology (88)
Bladder cancer (102)
Brain cancer (53)
Breast cancer (409)
Cancer (3135)
Cardiovascular disease (237)
Career advice (1520)
Career pathing (29)
CAR-T (164)
CDC (26)
Cell therapy (482)
Cervical cancer (24)
Clinical research (49975)
Collaboration (1195)
Company closure (2)
Compensation (352)
Complete response letters (29)
COVID-19 (2091)
CRISPR (68)
C-suite (431)
Cystic fibrosis (97)
Data (3757)
Decentralized trials (2)
Denatured (34)
Depression (82)
Diabetes (327)
Diagnostics (4678)
Digital health (27)
Diversity (6)
Diversity, equity & inclusion (31)
Drug discovery (192)
Drug pricing (100)
Drug shortages (21)
Duchenne muscular dystrophy (141)
Earnings (63329)
Editorial (41)
Employer branding (14)
Employer resources (99)
Events (77251)
Executive appointments (700)
FDA (13099)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (981)
Gene editing (126)
Generative AI (38)
Gene therapy (405)
GLP-1 (672)
Government (3159)
Grass and pollen (5)
Guidances (309)
Healthcare (14087)
HIV (35)
Huntington's disease (30)
IgA nephropathy (41)
Immunology and inflammation (148)
Immuno-oncology (8)
Indications (43)
Infectious disease (2236)
Inflammatory bowel disease (142)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (150)
Interviews (328)
IPO (10921)
IRA (38)
Job creations (2256)
Job search strategy (1261)
Kidney cancer (11)
Labor market (49)
Layoffs (316)
Leadership (28)
Legal (5253)
Liver cancer (59)
Longevity (11)
Lung cancer (453)
Lymphoma (210)
Machine learning (26)
Management (40)
Manufacturing (424)
MASH (102)
Medical device (8771)
Medtech (8787)
Mergers & acquisitions (12221)
Metabolic disorders (784)
Multiple sclerosis (118)
NASH (11)
Neurodegenerative disease (185)
Neuropsychiatric disorders (34)
Neuroscience (2403)
NextGen: Class of 2025 (4798)
Non-profit (3862)
Now hiring (22)
Obesity (343)
Opinion (226)
Ovarian cancer (103)
Pain (128)
Pancreatic cancer (129)
Parkinson's disease (215)
Partnered (24)
Patents (296)
Patient recruitment (226)
Peanut (35)
People (41173)
Pharmaceutical (23)
Pharmacy benefit managers (12)
Phase I (15913)
Phase II (21715)
Phase III (16503)
Pipeline (2331)
Policy (185)
Postmarket research (2076)
Preclinical (7240)
Press Release (60)
Prostate cancer (178)
Psychedelics (40)
Radiopharmaceuticals (205)
Rare diseases (477)
Real estate (3775)
Recruiting (46)
Regulatory (15913)
Reports (31)
Research institute (2369)
Resumes & cover letters (248)
Rett syndrome (13)
RNA editing (12)
RSV (42)
Schizophrenia (106)
Series A (168)
Series B (105)
Service/supplier (5)
Sickle cell disease (58)
Special edition (15)
Spinal muscular atrophy (127)
Sponsored (28)
Startups (2594)
State (1)
Stomach cancer (10)
Supply chain (57)
Tariffs (42)
The Weekly (69)
Vaccines (681)
Venture capital (46)
Weight loss (212)
Women's health (37)
Worklife (15)
Date
Last 7 days (565)
Last 30 days (1828)
Last 365 days (23935)
2025 (19367)
2024 (26837)
2023 (30083)
2022 (38501)
2021 (40916)
2020 (39270)
2019 (34527)
2018 (25751)
2017 (24059)
2016 (23602)
2015 (27163)
2014 (22248)
2013 (19483)
2012 (19709)
2011 (19434)
2010 (18164)
Location
Africa (705)
Alabama (70)
Alaska (6)
Arizona (141)
Arkansas (10)
Asia (30427)
Australia (5412)
California (6853)
Canada (2142)
China (695)
Colorado (295)
Connecticut (347)
Delaware (231)
Europe (70230)
Florida (1089)
Georgia (227)
Idaho (39)
Illinois (509)
India (39)
Indiana (359)
Iowa (13)
Japan (287)
Kansas (86)
Kentucky (32)
Louisiana (9)
Maine (38)
Maryland (937)
Massachusetts (5162)
Michigan (199)
Minnesota (355)
Mississippi (2)
Missouri (92)
Montana (21)
Nebraska (13)
Nevada (74)
New Hampshire (44)
New Jersey (2079)
New Mexico (25)
New York (1984)
North Carolina (942)
North Dakota (7)
Northern California (3228)
Ohio (189)
Oklahoma (17)
Oregon (23)
Pennsylvania (1421)
Puerto Rico (6)
Rhode Island (28)
South America (957)
South Carolina (28)
Southern California (2656)
Tennessee (120)
Texas (1077)
United States (25433)
Utah (202)
Virginia (155)
Washington D.C. (63)
Washington State (586)
West Virginia (4)
Wisconsin (59)
Wyoming (1)
511,228 Results for "brain and behavior discovery institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense
June 11, 2025
·
6 min read
Neurodegenerative disease
VectorY Bets up to $1.2B+ That Shape’s Brain-Penetrant Capsids Are a Fit
VectorY Therapeutics will evaluate the use of SHP-DB1, a capsid developed by Shape Therapeutics, to deliver therapies to the brain, including VectorY’s developmental Huntington’s and Alzheimer’s disease treatments.
September 18, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
October 21, 2025
·
5 min read
Press Releases
Brain Canada invests in the next generation of brain researchers with new Future Leaders grants
October 1, 2025
·
4 min read
Press Releases
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
October 21, 2025
·
3 min read
Press Releases
IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida’s Department of Psychiatry and Behavioral Neurosciences
October 15, 2025
·
4 min read
Press Releases
Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior
October 15, 2025
·
17 min read
Press Releases
Nicklaus Children’s Hospital Joins Children’s Brain Tumor Network to Advance Pediatric Brain Tumor Research
September 26, 2025
·
2 min read
Press Releases
Glioblastomas Affect Much More Than Just the Brain
October 3, 2025
·
6 min read
BioMidwest
Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Harrington Discovery Institute Center for Brain Health Medicines at University Hospitals and the Alzheimer’s Drug Discovery Foundation announce a joint request for proposals for the 2024 ADDF-Harrington Scholar Award.
April 1, 2024
·
4 min read
1 of 51,123
Next
